ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Common Chemotherapy Fertilizes Marrow Before Tumors Take Root

May 25, 2012

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

Dept. of Defense opens program announcements for prostate cancer research.

December 10, 2004

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

Obituary: Michael Potter, 89, NIH Researcher

June 26, 2013

Avastin Increases Overall Survival 3.7 Months

February 22, 2013